- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Treatment-resistant Multiple Myeloma
Total 13065 results
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Heidelberg Pharma AGRecruitingMultiple Myeloma | Plasma Cell DisorderUnited States, Germany, Poland, Hungary
-
Chunyan Sun, MDRecruiting
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
University of RochesterNational Cancer Institute (NCI)RecruitingMyelomaUnited States
-
Anaveon AGRecruitingLung Cancer | Advanced Solid Tumor | Adult DiseaseUnited Kingdom, Switzerland, Spain
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
TakedaRecruitingMultiple MyelomaKorea, Republic of
-
Fuling ZhouRecruiting
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Massachusetts General HospitalNot yet recruitingCovid19 | Multiple Myeloma | Waldenstrom Macroglobulinemia | Immune System DisorderUnited States
-
University of ChicagoRecruitingMultiple Myeloma | Cardiotoxicity | Dyspnea | Shortness of BreathUnited States
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
Keymed Biosciences Co.LtdRecruitingLymphoma | Multiple MyelomaChina
-
Cartesian TherapeuticsRecruiting
-
Hoag Memorial Hospital PresbyterianRecruiting
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
Tel-Aviv Sourasky Medical CenterRecruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseIsrael
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
Mayo ClinicRecruitingMultiple Myeloma | Autologous Stem Cell TransplantUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Chongqing Precision Biotech Co., LtdRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Neoplasm, Plasma CellChina
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Newave Pharmaceutical IncRecruitingAcute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | Chronic Myelomonocytic Leukemia-2 | Richter Transformation | T-cell-prolymphocytic Leukemia and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
C4 Therapeutics, Inc.RecruitingMultiple Myeloma | Lymphoma, Non-Hodgkin'sUnited States
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
University of RochesterRecruitingMultiple Myeloma | Prostate Cancer | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma (SMM)United States
-
HealthTree FoundationGlaxoSmithKlineRecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma | CoronavirusUnited States
-
Sichuan UniversityRecruiting
-
Hadassah Medical OrganizationNexcella, IncRecruiting
-
University Hospital, MontpellierRecruitingLymphoma | Multiple Myeloma | Olfactivo-gustatory Disorder | Haematological CancerFrance
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Recruiting
-
Second Affiliated Hospital, School of Medicine,...Carbiogene Therapeutics Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Assistance Publique - Hôpitaux de ParisINSERM UMR 1163Not yet recruitingMultiple Myeloma | Waldenstrom Macroglobulinemia | Monoclonal Gammopathy of Undetermined SignificanceFrance
-
University of PennsylvaniaGlaxoSmithKlineRecruiting
-
Ascentage Pharma Group Inc.Recruiting
-
Zhejiang UniversityYake Biotechnology Ltd.Not yet recruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaChina
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Wuhan Union Hospital, ChinaWuhan Si'an Medical Technology Co., LtdRecruitingCS1+ or BCMA+ Multiple MyelomaChina
-
University of TennesseeAstraZeneca; Vanderbilt University Medical CenterRecruitingMultiple Myeloma | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Multiple Chronic ConditionsUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non-hodgkin's LymphomaChina
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingMultiple MyelomaUnited Kingdom
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
University of CologneJanssen-Cilag G.m.b.HRecruiting
-
Jacob Laubach, MDSanofiRecruitingMultiple Myeloma | Autologous Stem Cell Transplant | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan